The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis
Authors:
- 25 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 208 (1) , 71-79
Abstract
Purpose:The role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) was challenged by the results of the CARMENA trial. Here we evaluate the role of CN in mRCC patients, in...Keywords
This publication has 16 references indexed in Scilit:
- Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2018
- Development and Validation of a High‐Quality Composite Real‐World Mortality EndpointHealth Services Research, 2018
- Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy eraInternational Journal of Cancer, 2013
- Generalized propensity score for estimating the average treatment effect of multiple treatmentsStatistics in Medicine, 2011
- Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?Cancer, 2010
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- Immortal Time Bias in PharmacoepidemiologyAmerican Journal of Epidemiology, 2007
- Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined AnalysisJournal of Urology, 2004
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trialThe Lancet, 2001
- Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 1999